Real-World Multiple Myeloma Risk Factors and Outcomes By Race/Ethnicity in the United States

被引：0
|
作者：
Buck, Tondre T. [1 ]
Salinardi, Taylor [2 ]
Rice, Megan S. [2 ]
机构：
[1] Spartanburg Med Ctr, Ctr Hematol Oncol, Spartanburg, SC USA
[2] Sanofi, Cambridge, MA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5216 / 5217
页数：2
相关论文
共 50 条
  • [31] Real-world outcomes of venetoclax refractory multiple myeloma patients.
    Maples, Kathryn T.
    Kaufman, Jonathan L.
    Gupta, Vikas Anand
    Joseph, Nisha
    Heffner, Leonard T.
    Hofmeister, Craig C.
    Dhodapkar, Madhav, V
    Matulis, Shannon M.
    Boise, Lawrence
    Lonial, Sagar
    Nooka, Ajay K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China
    Tang, Wenjiao
    Yang, Jinrong
    Li, Yan
    Zhang, Li
    Li, He
    Wang, Jie
    Liao, Yi
    Zhang, Chunlan
    Qu, Ying
    Zheng, Yuhuan
    Niu, Ting
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Real-World Association of Race/Ethnicity with Adverse Maternal and Fetal Outcomes in Women with Diabetes
    Farrokhi, Farnoosh
    Guo, Yian
    Scott, Alexandra
    Lane, Rashon
    Kerr, David
    [J]. DIABETES, 2024, 73
  • [34] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [35] Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
    Atrash, Shebli
    Flahavan, Evelyn M.
    Xu, Tao
    Ma, Esprit
    Karve, Sudeep
    Hong, Wan-Jen
    Jirau-Lucca, Gilbert
    Nixon, Michael
    Ailawadhi, Sikander
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (03)
  • [36] Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
    Shebli Atrash
    Evelyn M. Flahavan
    Tao Xu
    Esprit Ma
    Sudeep Karve
    Wan-Jen Hong
    Gilbert Jirau-Lucca
    Michael Nixon
    Sikander Ailawadhi
    [J]. Blood Cancer Journal, 12
  • [37] Real-World Outcomes of High-Risk Multiple Myeloma: Retrospective Analysis of Cams&pumc
    Sui, Weiwei
    Deng Shuhui
    An Gang
    Yan Xu
    Yi, Shuhua
    Zou Dehui
    Qiu, Lugui, Sr.
    [J]. BLOOD, 2018, 132
  • [38] Real-world treatment patterns, comorbidities, and disease-related complications in patients with multiple myeloma in the United States
    Song, Xue
    Cong, Ze
    Wilson, Kathleen
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (01) : 95 - 103
  • [39] EVALUATION OF CARDIOVASCULAR EVENTS ASSOCIATED WITH DIFFERENT TREATMENT MODALITIES OF MULTIPLE MYELOMA IN THE REAL-WORLD SETTING IN THE UNITED STATES
    Lenihan, D.
    Potluri, R.
    Kanakamedala, H.
    Dasgupta, A.
    Chen, C.
    [J]. HAEMATOLOGICA, 2017, 102 : 514 - 514
  • [40] Asthma biologic trial eligibility and real-world outcomes in the United States
    Lam, Regina W.
    Inselman, Jonathan W.
    Jeffery, Molly M.
    Maddux, Jacob T.
    Shah, Nilay D.
    Rank, Matthew A.
    [J]. JOURNAL OF ASTHMA, 2022, 59 (12) : 2352 - 2359
12345